NeuroSense Therapeutics Ltd.
$3.07
-0.10 (-3.15%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -54.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -70.0%
Own NRSN?
See how NRSN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.